Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mengdi Guo

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Immunity|January 30, 2021
Early innate and adaptive immune perturbations determine long-term severity of chronic virus and Mycobacterium tuberculosis coinfectionWenxi Xu, Laura M Snell, Mengdi Guo, et al.
Cell Reports|August 31, 2023
Molecular, metabolic, and functional CD4 T cell paralysis in the lymph node impedes tumor controlMengdi Guo, Diala Abd-Rabbo, Bruna C Bertol, et al.
Optics Letters|May 1, 2025
Compressive phase-shifting fringe projection profilometry for accelerating 3D metrologyBozhang Cheng, Yunhua Yao, Yu He, et al.
Nature Immunology|November 19, 2021
Dynamic CD4<sup>+</sup> T cell heterogeneity defines subset-specific suppression and PD-L1-blockade-driven functional restoration in chronic infectionLaura M Snell, Wenxi Xu, Diala Abd-Rabbo, et al.
The Journal of Clinical Investigation|October 15, 2025
ANKRD55 is a key regulator of T cell inflammation in multiple sclerosisChuyu Wu, Meiling Jiang, Xue Yang, et al.
Frontiers in Oncology|June 6, 2019
Validation of CyTOF Against Flow Cytometry for Immunological Studies and Monitoring of Human Cancer Clinical TrialsRamy Gadalla, Babak Noamani, Bethany L MacLeod, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2026
Sequential infection reprograms the immune landscape to shape future responsesMengdi Guo, Yanis Hichem Bouzaher, Diala Abd-Rabbo, et al.
Science Immunology|December 15, 2019
GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironmentMarie Jo Halaby, Kebria Hezaveh, Sara Lamorte, et al.
Immunity|November 12, 2022
The transcription factor IRF2 drives interferon-mediated CD8<sup>+</sup> T cell exhaustion to restrict anti-tumor immunitySabelo Lukhele, Diala Abd Rabbo, Mengdi Guo, et al.
Nature Immunology|July 14, 2022
Pre-encoded responsiveness to type I interferon in the peripheral immune system defines outcome of PD1 blockade therapyGiselle M Boukhaled, Ramy Gadalla, Heidi J Elsaesser, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Immunity|January 30, 2021
Early innate and adaptive immune perturbations determine long-term severity of chronic virus and Mycobacterium tuberculosis coinfectionWenxi Xu, Laura M Snell, Mengdi Guo, et al.
Cell Reports|August 31, 2023
Molecular, metabolic, and functional CD4 T cell paralysis in the lymph node impedes tumor controlMengdi Guo, Diala Abd-Rabbo, Bruna C Bertol, et al.
Optics Letters|May 1, 2025
Compressive phase-shifting fringe projection profilometry for accelerating 3D metrologyBozhang Cheng, Yunhua Yao, Yu He, et al.
Nature Immunology|November 19, 2021
Dynamic CD4<sup>+</sup> T cell heterogeneity defines subset-specific suppression and PD-L1-blockade-driven functional restoration in chronic infectionLaura M Snell, Wenxi Xu, Diala Abd-Rabbo, et al.
The Journal of Clinical Investigation|October 15, 2025
ANKRD55 is a key regulator of T cell inflammation in multiple sclerosisChuyu Wu, Meiling Jiang, Xue Yang, et al.
Frontiers in Oncology|June 6, 2019
Validation of CyTOF Against Flow Cytometry for Immunological Studies and Monitoring of Human Cancer Clinical TrialsRamy Gadalla, Babak Noamani, Bethany L MacLeod, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2026
Sequential infection reprograms the immune landscape to shape future responsesMengdi Guo, Yanis Hichem Bouzaher, Diala Abd-Rabbo, et al.
Science Immunology|December 15, 2019
GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironmentMarie Jo Halaby, Kebria Hezaveh, Sara Lamorte, et al.
Immunity|November 12, 2022
The transcription factor IRF2 drives interferon-mediated CD8<sup>+</sup> T cell exhaustion to restrict anti-tumor immunitySabelo Lukhele, Diala Abd Rabbo, Mengdi Guo, et al.
Nature Immunology|July 14, 2022
Pre-encoded responsiveness to type I interferon in the peripheral immune system defines outcome of PD1 blockade therapyGiselle M Boukhaled, Ramy Gadalla, Heidi J Elsaesser, et al.
Pageof 7